Literature DB >> 15646027

Aspirin-induced apoptosis in jurkat cells is not mediated by peroxisome proliferator-activated receptor delta.

José M López1, Manuel A Fernández, Maria Piqué, Joan Gil.   

Abstract

Nonsteroidal antiinflammatory drugs may induce apoptosis via inhibition of peroxisome proliferator-activated receptor delta (PPARdelta) activity. Here we analyze the role of PPARdelta in aspirin-induced apoptosis of Jurkat cells, which, together with other lymphoid cell lines, express PPARdelta mRNA. Aspirin increased PPARdelta mRNA levels in Jurkat cells, but decreased the activity of both PPARdelta and PPARalpha/gamma, assayed using the luciferase reporter constructs DRE and ACO, respectively. The DNA binding of PPARdelta was not affected by 10 mM aspirin, which induces apoptosis in Jurkat cells. Moreover, neither addition of a specific ligand of PPARdelta nor transient transfection of PPARdelta expression vectors protected Jurkat cells from aspirin-induced apoptosis. These results indicate that PPARdelta is not involved in aspirin-induced apoptosis. Therefore, the mechanism by which aspirin mediates cell death in Jurkat cells remains unknown.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15646027     DOI: 10.1023/b:mcbi.0000049138.67699.7b

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

Review 1.  Roles of PPARs in health and disease.

Authors:  S Kersten; B Desvergne; W Wahli
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

2.  Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids.

Authors:  A Schmidt; N Endo; S J Rutledge; R Vogel; D Shinar; G A Rodan
Journal:  Mol Endocrinol       Date:  1992-10

Review 3.  Cyclooxygenase-independent actions of cyclooxygenase inhibitors.

Authors:  I Tegeder; J Pfeilschifter; G Geisslinger
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

Review 4.  Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions.

Authors:  S J Shiff; B Rigas
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682

Review 5.  Adipogenesis and obesity: rounding out the big picture.

Authors:  B M Spiegelman; J S Flier
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

Review 6.  Cyclooxygenases 1 and 2.

Authors:  J R Vane; Y S Bakhle; R M Botting
Journal:  Annu Rev Pharmacol Toxicol       Date:  1998       Impact factor: 13.820

7.  Peroxisome proliferator-activated receptor beta expression in human breast epithelial cell lines of tumorigenic and non-tumorigenic origin.

Authors:  Kate M Suchanek; Fiona J May; Won Jae Lee; Nicola A Holman; Sarah J Roberts-Thomson
Journal:  Int J Biochem Cell Biol       Date:  2002-09       Impact factor: 5.085

8.  Sulindac inhibits activation of the NF-kappaB pathway.

Authors:  Y Yamamoto; M J Yin; K M Lin; R B Gaynor
Journal:  J Biol Chem       Date:  1999-09-17       Impact factor: 5.157

9.  Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.

Authors:  S A Kliewer; B M Forman; B Blumberg; E S Ong; U Borgmeyer; D J Mangelsdorf; K Umesono; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

10.  Aspirin induces cell death and caspase-dependent phosphatidylserine externalization in HT-29 human colon adenocarcinoma cells.

Authors:  E Castaño; M Dalmau; M Barragán; G Pueyo; R Bartrons; J Gil
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

View more
  3 in total

Review 1.  Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.

Authors:  Jeffrey M Peters; Holly E Hollingshead; Frank J Gonzalez
Journal:  Clin Sci (Lond)       Date:  2008-08       Impact factor: 6.124

2.  The PPARδ ligand GW501516 reduces growth but not apoptosis in mouse inner medullary collecting duct cells.

Authors:  Jordan Clark; Rania Nasrallah; Richard L Hébert
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964

3.  NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?

Authors:  Gerardo G Mackenzie; Shaheen Rasheed; William Wertheim; Basil Rigas
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.